Latest / JACC Specialty Journals
JACC: Basic to Translational Science - Effect of Crizanlizumab, a P-selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial
Commentary by Dr. Douglas Mann
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.